Professor Du's group at RIT is using Precigenome Pressure Controller PG-MFC for their study.
Dr. Ke Du in RIT's Kate Gleason College of Engineering is developing a microfluidic device that utilizes CRISPR gene-editing technology to monitor and detect the nucleic acid markers for Ebola virus. They have also been developing a prototype micro-device with bio-sensors that can detect the Ebola virus earlier. With this powerful device, the infected people can be treated earlier and the early detection process can potentially decrease the spread of infections.